#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 20

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Cardiac amyloidosis

Not recruiting

InvestigationalNo placebo

Study on the Safety of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy Who Completed a Previous Trial

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Acoramidis Hydrochloride

Contact Research Centre

Fallopian tube cancer+2

Not recruiting

Registered drugNo placebo

Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Nemvaleukin Alfa

Contact Research Centre

Liposarcoma

Not recruiting

Registered drugNo placebo

Study Comparing BI 907828 and Doxorubicin for Patients with Advanced Dedifferentiated Liposarcoma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:(3S,3'S,3A's,10A's)-6-Chloro-3'-(3-Chloro-2-Fluorophenyl)-1'-(Cyclopropylmethyl)-6'-Methyl-2-Oxo-1,2,3',3A',10',10A'-Hexahydro-1'H-Spiro[Indole-3,2'-Pyrrolo[2',3':4,5]Pyrrolo[1,2-B]Indazole]-7'-Carboxylic Acid

Contact Research Centre

Breast cancer metastatic

Not recruiting

Registered drugNo placebo

Study of Disulfiram and Copper for Patients with Metastatic Breast Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Disulfiram

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Dacarbazine

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Avelumab

Contact Research Centre

Cardiac amyloidosis

Not recruiting

Investigational

Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Eplontersen

Contact Research Centre

Hypertriglyceridaemia

Not recruiting

Investigational

Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues

Contact Research Centre

Relapsing-remitting multiple sclerosis

Not recruiting

Investigational

Study on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis

Investigational

Czechia

Participants:18–64 years
Substances:Obexelimab

Contact Research Centre

EGFR gene mutation+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Bay 2927088

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.